SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement

The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.

SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) have launched joint laboratories to produce novel cell therapies that meet good manufacturing practice (GMP) standards.

With a combined funding of almost $30m, the partnership will focus on induced pluripotent stem cell (iPSC) technology and develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates.

"The discovery of iPSCs has revolutionised regenerative medicine, offering the potential for standardised, off-the-shelf cell therapies.” Koh Boon Tong, Executive Director, A*STAR's BTI, said.

ALSO READ: NUH to establish health centre for early cancer detection in 2025

The joint laboratories are established at SCG’s GMP facility and A*STAR’s research facility.

Meanwhile, the two organisations also plan to establish a talent development programme to conduct training following current GMP and regulatory requirements.

Follow the link for more news on

healthcare

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia